From January 31, 2023 to January 31, 2023, the company has repurchased 468,308 shares, representing 2.57% for $1.4 million. With this, the company has completed the repurchase of 468,308 shares, representing 2.57% for $1.4 million under the buyback announced on February 2, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.155 USD | -0.99% | +2.13% | -0.23% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.23% | 18.4M | |
+30.38% | 695B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 330B | |
+3.73% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+7.68% | 168B |
- Stock Market
- Equities
- PMCB Stock
- News PharmaCyte Biotech, Inc.
- Tranche Update on PharmaCyte Biotech, Inc.'s Equity Buyback Plan announced on February 2, 2023.